The US FDA is launching a pilot program to encourage sponsors to develop innovative clinical trial designs and dispel the perception that the agency will not accept novel protocols.
FDA officials gave a preview of the program, which has yet to be announced in the Federal Register, at a March 20 public workshop on promoting the use of complex innovative designs in clinical trials of drugs and biological products
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?